JPWO2021024742A1 - - Google Patents
Info
- Publication number
- JPWO2021024742A1 JPWO2021024742A1 JP2020573047A JP2020573047A JPWO2021024742A1 JP WO2021024742 A1 JPWO2021024742 A1 JP WO2021024742A1 JP 2020573047 A JP2020573047 A JP 2020573047A JP 2020573047 A JP2020573047 A JP 2020573047A JP WO2021024742 A1 JPWO2021024742 A1 JP WO2021024742A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019144490 | 2019-08-06 | ||
| PCT/JP2020/027655 WO2021024742A1 (ja) | 2019-08-06 | 2020-07-16 | 細胞傷害アッセイ方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2021024742A1 true JPWO2021024742A1 (pl) | 2021-02-11 |
Family
ID=74503107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573047A Pending JPWO2021024742A1 (pl) | 2019-08-06 | 2020-07-16 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2021024742A1 (pl) |
| WO (1) | WO2021024742A1 (pl) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2340745T3 (es) * | 1998-12-23 | 2010-06-08 | Pfizer Inc. | Anticuerpos monoclonales humanos contra ctla-4. |
| AU2002240818C1 (en) * | 2001-03-14 | 2008-11-06 | Agilent Technologies, Inc. | MHC molecule constructs and their uses for diagnosis and therapy |
| ES2633389T3 (es) * | 2003-01-30 | 2017-09-21 | Survac Aps | Péptidos derivados de survivina y uso de los mismos |
| DK3038609T3 (da) * | 2013-08-27 | 2021-09-13 | Deutsches Krebsforsch | Cytotoksiske t-cellereaktionsmodifikatorer |
-
2020
- 2020-07-16 JP JP2020573047A patent/JPWO2021024742A1/ja active Pending
- 2020-07-16 WO PCT/JP2020/027655 patent/WO2021024742A1/ja active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021024742A1 (ja) | 2021-02-11 |